(HealthDay)—Physicians have a large economic impact across the nation, creating an aggregate of $2.3 trillion of economic activity and supporting employment of nearly 12.6 million Americans, according to a report published ...
Jan 11, 2018
0
1
The income gap between the rich and poor in the United States has reached its highest levels since the Great Depression. Given past evidence that a wider rich-poor gap can be harmful to a population's health, tax policies ...
Nov 27, 2017
0
0
Raising tobacco taxes to increase cigarette prices could reduce cigarette consumption and smoking-associated deaths (SADs) in all 28 EU countries, according to a study published in the open access journal BMC Public Health.
Sep 20, 2017
0
0
Mylan's second-quarter profit and revenue surged, but not as much as Wall Street had expected and the company is taking a more conservative view going forward because of "ongoing challenges and the uncertain U.S. regulatory ...
Aug 9, 2017
0
0
(HealthDay)—Risk adjustment and reinsurance transfer programs seem to have been effective for increasing revenues at the expense of claims costs, according to research published in the March issue of Health Affairs.
Apr 7, 2017
0
0
Four states legalized recreational marijuana in November, nearly doubling the number of states where recreational pot is legal. As more states consider joining them, a range of arguments for and against legalization is swirling ...
Mar 8, 2017
0
0
(HealthDay)—Even as Republicans in Congress race to repeal the Affordable Care Act, the IRS is reminding millions of Americans they still need to sign up soon for health insurance if they don't want to pay fines.
Jan 16, 2017
0
0
Guam Gov. Eddie Calvo has proposed legalizing recreational marijuana on the island, with heavy taxation.
Dec 20, 2016
0
0
Some $350 million in cuts to a Texas Medicaid program providing therapy for disabled children have taken effect.
Dec 16, 2016
0
0
Swiss drug company Novartis saw net profit slip in the third quarter as the loss of a key drug to generic use in the United States outweighed strong sales of its psoriasis drug Cosentyx and MS treatment Gilenya.
Oct 25, 2016
0
0
